Site content in development. Please email for assistance.

AI developed for staging patients with prostate cancer



Nicolo Capobianco, PhD, a research scientist at Siemens Healthineers in Erlangen, Germany, and colleagues at the Lawson Health Research Institute in London, Ontario, developed a model that identifies regions suspicious for cancer and that agreed with a physician expert.

“The proposed method is promising to support prostate cancer staging based on PSMA-ligand PET/CT,” Capobianco told attendees in a June 24 session on basic and translational oncology research.

In recent years, researchers have developed PET radiotracers that reveal prostate cancer based on their ability to bind to…


Go to publisher site for the complete article:

Read More

Radiology AI
Compare items
  • Total (0)